Serine protease inhibitors and cytotoxic T lymphocytes

被引:0
|
作者
Ashton-Rickardt, Philip G. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Immunol, London W12 0NN, England
基金
英国惠康基金; 美国国家卫生研究院; 英国医学研究理事会;
关键词
serine protease inhibitors; cytotoxic T cells; apoptosis; GRANZYME-B INHIBITOR; CELLS IN-VIVO; RENAL-ALLOGRAFT REJECTION; PERFORIN-DEFICIENT MICE; MEDIATED CYTOTOXICITY; VIRAL-INFECTION; DENDRITIC CELLS; STEM-CELLS; TRANSCRIPTION FACTOR; INDUCED APOPTOSIS;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Serine proteases control a wide variety of physiological and pathological processes in multi-cellular organisms, including blood clotting, cancer, cell death, osmoregulation, tissue remodeling, and immunity to infection. Cytotoxic T lymphocytes (CTLs) are required for adaptive cell-mediated immunity to intracellular pathogens by killing infected cells and through the development of memory T cells. Serine proteases not only allow a CTL to kill but also impose homeostatic control on CTL number. Serine protease inhibitors (serpins) are the physiological regulators of serine proteases' activity. In this review, I discuss the role of serpins in controlling the recognition of antigen, effector function, and homeostatic control of CTLs through the inhibition of physiological serine protease targets. An emerging view of serpins is that they are important promoters of cellular viability through their inhibition of executioner proteases. This view is discussed in the context of the T-lymphocyte survival during effector responses and the development and persistence of long-lived memory T cells. Given the important role serpins play in CTL immunity, I discuss the potential for developing new immunotherapeutic approaches based directly on serpins or knowledge gained from identifying their physiologically relevant protease targets.
引用
收藏
页码:147 / 158
页数:12
相关论文
共 50 条
  • [31] CLONING OF A CDNA FOR A-T CELL-SPECIFIC SERINE PROTEASE FROM A CYTOTOXIC LYMPHOCYTE-T
    GERSHENFELD, HK
    WEISSMAN, IL
    SCIENCE, 1986, 232 (4752) : 854 - 858
  • [32] TRANSCRIPTIONAL REGULATION OF 2 CYTOTOXIC-T LYMPHOCYTE-SPECIFIC SERINE PROTEASE GENES
    LOBE, CG
    SHAW, J
    FREGEAU, C
    DUGGAN, B
    MEIER, M
    BREWER, A
    UPTON, C
    MCFADDEN, G
    PATIENT, RK
    PAETKAU, V
    BLEACKLEY, RC
    NUCLEIC ACIDS RESEARCH, 1989, 17 (14) : 5765 - 5779
  • [33] BIFUNCTIONAL SERINE PROTEASE INHIBITORS OF HUMAN PLATELETS
    BAGDASARIAN, A
    COLMAN, RW
    FEDERATION PROCEEDINGS, 1976, 35 (07) : 1765 - 1765
  • [34] Potential of pyrazolooxadiazinone derivatives as serine protease inhibitors
    Vicentini, CB
    Guarneri, M
    Andrisano, V
    Guccione, S
    Langer, T
    Marschhofer, R
    Chabin, R
    Edison, AM
    Huang, X
    Knight, WB
    Giori, P
    JOURNAL OF ENZYME INHIBITION, 2001, 16 (01): : 15 - +
  • [35] Novel noncovalent inhibitors of the HCV serine protease
    Edwards, P. J.
    Bailey, M. D.
    Bhardwaj, P. K.
    Boes, M.
    Cordingley, M. G.
    Forgione, P.
    Goudreau, N.
    Lemke, C.
    White, P. W.
    Llinas-Brunet, M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [36] Anionic tetrahedral complexes as serine protease inhibitors
    Shokhen, M
    Arad, D
    JOURNAL OF MOLECULAR MODELING, 1996, 2 (10): : 390 - 398
  • [37] Engineering of GFP for the screening of serine protease inhibitors
    Vera, A
    Arís, A
    Daura, X
    Martínez, MA
    Villaverde, A
    FEBS JOURNAL, 2005, 272 : 177 - 177
  • [38] β-Sultams -: A novel class of serine protease inhibitors
    Beardsell, M
    Hinchliffe, PS
    Wood, JM
    Wilmouth, RC
    Schofield, CJ
    Page, MI
    CHEMICAL COMMUNICATIONS, 2001, (05) : 497 - 498
  • [40] Serpins and other serine protease inhibitors - Comment
    Patston, PA
    IMMUNOLOGY TODAY, 2000, 21 (07): : 354 - +